BEGIN:VCALENDAR
PRODID: University of Exeter
VERSION:2.0
BEGIN:VTIMEZONE
TZID:Europe/London
X-LIC-LOCATION:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240429T153000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20240429T153000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10
END:STANDARD
END:VTIMEZONE
METHOD:PUBLISH
BEGIN:VEVENT
SUMMARY; CHARSET=UTF-8 :EGENIS seminar: "Tactical reporting, actionability and uncertainty in the genomic clinic  ", Prof Adam Hedgecoe (Cardiff University)
UID:exeter_event_13710
URL:http://www.exeter.ac.uk/events/details/?event=13710
DTSTART;VALUE=DATE:20240429T153000
DTEND;VALUE=DATE:20240429T170000
X-MICROSOFT-CDO-ALLDAYEVENT:FALSE
ORGANIZER: MAILTO:
ATTACH: http://www.exeter.ac.uk/events/details/?event=13710
DTSTAMP:20240325T092139
LOCATION:Hybrid
DESCRIPTION; CHARSET=UTF-8 :Drawing on ethnographic observations in over 290 clinical team meetings and covering a range of conditions from inherited heart disease, cancer, developmental delays and dysmorphia, this paper seeks to explore professional decision making around clinical genomic sequencing. With a specific focus on decisions about a particular kind of ambiguous result – called Variants of Uncertain Significance (VUS) – this paper examines the role of the perceived ‘actionability’ of specific genomic results. The key insight centres on the way in which clinicians’ beliefs about how parents will react to a result feed back into decisions about the status of such ambiguous results, builds on previous STS work around actionability from Nicole Nelson, Alberto Cambrosio and Stefan Timmermans.http://www.exeter.ac.uk/events/details/?event=13710
SEQUENCE:0
PRIORITY:5
CLASS:
STATUS:CONFIRMED
TRANSP:TRANSPARENT
X-MICROSOFT-CDO-IMPORTANCE:1
X-Microsoft-CDO-BUSYSTATUS:FREE
X-MICROSOFT-CDO-INSTTYPE:0
X-Microsoft-CDO-INTENDEDSTATUS:FREE
END:VEVENT
END:VCALENDAR